Khiron investor relations
WebStrength and Security Information and History Awards News at IBKR Press and Media Investor Relations Sustainability Regulatory Reports Refer a Friend. Support. Fund Your Account For Individuals For Institutions Institutional Sales Contacts Browse Our FAQs Tax Information. Language. Web4 okt. 2024 · -Khiron Life Sciences Corp., a vertically integrated cannabis leader with core operations in Latin America and Europe, is scheduled to participate in the following virtual investor conferences in ...
Khiron investor relations
Did you know?
Web27 apr. 2024 · If you have any difficulty connecting with the conference call, please contact Khiron Investor Relations team at (647) 556-5750 A telephonic replay of the conference call will also be available... Web4 apr. 2024 · The second half of 2024 was bruising for the cannabis industry, prompting changes in strategy for just about every company. Retailers of all varieties—from single-store mom-and-pop businesses to publicly traded multistate operators (MSOs)—are reevaluating how their stores function and whether they are optimally designed for this …
WebContacts and General Information :: Khiron Life Sciences Corp. (KHRN) Contacts and General Information T: 1 (647) 556-5750 [email protected] Have a business-related … WebAird & Berlis LLP ‘s team has experience advising clients in both the medicinal and recreational cannabis markets. Clients include producers, packagers, consumer packaged goods companies, processors and investors and the group leverages vast knowledge in financings and restructurings, and often advises clients in distressed circumstances.
Web4 okt. 2024 · Members of the Khiron management will also be holding one-on-one investor meetings throughout the day. For more information about the conference or to schedule a 1-on-1 meeting with Khiron management, please call the company’s investor relations team at 1-647-556-5750. Interested parties for the MJBizCon can register to attend here. Web16 feb. 2024 · Khiron Life Sciences Announces Closing of Marketed Offering Including Full Exercise of Over-Allotment Option 2024-04-04 9:30 AM EDT; Khiron Closes Additional …
WebKhiron has sales in Colombia, Peru, Brazil, UK and Germany Mexico to be added by year end. Khiron is shopping for a clinic deal. Plans to build out clinics in the UK to better build the market there. The NHS is hesitant to write Cannabis prescriptions.
WebKhiron Life Sciences (TSXV: KHRN), (OTCQX: KHRNF), (Frankfurt: A2JMXC) is a vertically integrated global medical and CPG cannabis leader with core operations in Latin America and Europe. We currently have distribution throughout various countries in Latin America, along with activity in North America and Europe. prognosis for lupus in womenWebReports and Presentations. WANdisco plc was admitted to trading on AIM on 1 June 2012. As a public company, WANdisco is committed to providing investors and its financial … kyc verification using blockchainWeb14 apr. 2024 · Toronto, Ontario--(Newsfile Corp. - April 14, 2024) - PharmaDrug Inc. (CSE: PHRX) (OTCQB: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances and natural medicines such as psychedelics and naturally-derived approved … kyc with blockchainWebKhiron is well-positioned to take advantage of the emerging global cannabis opportunity. OUR PRODUCTION FACILITY Cultivation: Upwards 0f 9 tonnes of dry flower. Fully … prognosis for lung cancer without treatmentWeb7 mrt. 2024 · For more information about the conferences or to schedule a 1-on-1 meeting with the Khiron management, please contact the company's investor relations team at [email protected] About Khiron Life ... prognosis for lupus nephritisWeb14 apr. 2024 · Toronto, Ontario–(Newsfile Corp. – April 14, 2024) – PharmaDrug Inc. (CSE: PHRX) (OTCQB: LMLLF) (“PharmaDrug” or the “Company“), a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances and natural medicines akin to psychedelics and naturally-derived approved … prognosis for lymphoma brain cancerWebKhiron invites individual and institutional investors, as well as advisors and analysts, to attend the Company's Third Quarter 2024 Conference Call, followed by a Q&A session. Read here: https ... prognosis for lung cancer stage 2